共 50 条
- [2] Clinical utility of 18F-Fluciclovine PET/CT in recurrent prostate cancer with very low (≤0.3 ng/mL) prostate-specific antigen levels [J]. AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 11 (05): : 406 - 414
- [4] Performance of 18F-Fluciclovine PET/CT for detection of recurrent prostate cancer, with a focus on low PSA levels (< 1 ng/mL): A single institution experience. [J]. JOURNAL OF NUCLEAR MEDICINE, 2020, 61
- [5] Positive Findings on 18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer and PSA levels ≤ 0.5 and ≤ 0.3 ng/ml [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S161 - S161
- [8] Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL [J]. Molecular Imaging and Biology, 2022, 24 : 42 - 49